Abbott India Ltd

Overview

Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories, discovers, develops, manufactures and markets a diverse range of branded generic pharmaceuticals, diagnostic tools, nutritional products, and diabetes and vascular devices. Its product portfolio encompasses multi-specialty drugs, vitamins and a comprehensive range of products for the treatment of hypothyroidism, vertigo, epilepsy, depression and migraine. The company’s offerings also include vaccines for influenza, typhoid and diarrhea. Abbott India develops pharmaceuticals in various formulations including tablets, liquids, injectables, ointments, granules, powder and capsules. The product range helps treat gynecological, gastroenterological, urological and neurological diseases, diabetes, pain and infection. Abbott India is headquartered in Mumbai, Maharashtra, India and has a manufacturing facility in Goa, India.
Key Stats
Address
3-4 Corporate Park, Sion-Trombay Road, Chembur, MUMBAI, India
Headquarters

India

Contact

91 22 38162000

No of Employees

3,585

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

ABBOTINDIA [NSE]

Revenue (2021)

$583 m

5.3% (2021 vs 2020)
Net Income (2021)

$93 m

15.9% (2021 vs 2020)
Net Profit Margin

16 %

10.6% (2021 vs 2020)
Market Cap *

$5,814 m

EPS *

$4.4

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Abbott India LtdAurobindo Pharma LtdCipla LtdDr. Reddy's Laboratories Ltd
Key Information
Headquarters India India India India
Headquarter City MUMBAI HYDERABAD MUMBAI HYDERABAD
Headquarter State/Province - - - -
No. of Employees 3,585 19,364 21,565 22,739
Entity Type Public Public Public Public

Products & Services

Abbott India is pharmaceutical company. The company offers its products in the following therapeutic areas:

Products
  • Allergy:
  • Ebasil
  • Solspre
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Brands
  • Arachitol
  • Brufen
  • Cremaffin
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Rajiv Sonalker Chief Financial Officer; Director Executive Board 2021 - Mr. Rajiv Sonalker is the Chief Financial Officer and Director. Prior to this, he was the Director of Finance. Prior...
Anil Joseph Director; Managing Director Executive Board 2020 - Mr. Anil Joseph is the Managing Director of the company. Prior to this, he has worked at Abbott Laboratories, Singapore...
Munir Shaikh Chairman Executive Board - - Mr. Munir Shaikh is the Chairman of the company. Prior to this, he held several management positions with Abbott Asia,...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 New Products/Services In July, the company launched COVID-19 Antigen Self-Test Kit, Panbio in India.
2021 New Products/Services In June, the company launched Amplatzer Piccolo Occluder in India for the treatment of premature…
2021 New Products/Services In March, the company the company announced the launch of Abbott Pandemic Defense Coalition dedicated…
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
02 Apr 2018 Corona Remedies Acquires Obimet and Thyrocab from Abbott Asset Transaction Corona Remedies Pvt Ltd Abbott India Ltd
19 Jul 2016 Abbott India May Sell Low-End Brands Asset Transaction Abbott India Ltd
31 Mar 2016 Abbott India Enters into Licensing Agreement with Bharat Biotech Licensing Agreement Abbott India Ltd Bharat Biotech Ltd
02 Aug 2012 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
03 May 2012 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
19 Feb 2008 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit